CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing cancer treatment by identifying new drug candidates that target transcription termination. A novel methodology has been developed to measure these alterations, with plans to create a screening platform for small molecule inhibitors.
Our value proposition is improving cancer therapy by identification of novel anti-cancer candidate drug leads modulating transcription termination, bridging molecular cancer biology and therapeutic applications.We have developed a methodology to directly measure alterations in transcription termination and successfully subjected it to miniaturization and automatization processes.
We are applying for funding to validate a screening platform to identify small molecule inhibitors of transcription t…
UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
